1 / 4

GDC-0941

Fig. S1. 54.6%. 91.5%. 89.6%. 93.2%. 59.3%. 88.3%. 89.8%. 91.7%. 56.4%. 32.1%. 33.7%. 20.0%. Control. ZSTK474. GDC-0941. NVP-BEZ235. 24h. 48h. Control. Paclitaxel. SN-38. CDDP. 48h. Fig. S2. control. ZSTK. GDC. NVP. Time (h). 0. 24. 48. 24. 48. 24. 48. 24. 48.

aram
Download Presentation

GDC-0941

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fig. S1 54.6% 91.5% 89.6% 93.2% 59.3% 88.3% 89.8% 91.7% 56.4% 32.1% 33.7% 20.0% Control ZSTK474 GDC-0941 NVP-BEZ235 24h 48h Control Paclitaxel SN-38 CDDP 48h

  2. Fig. S2 control ZSTK GDC NVP Time (h) 0 24 48 24 48 24 48 24 48 Phospho-Akt Phospho-4E-BP1 Phospho-S6 Phopho-Rb P.C. Cleaved PARP

  3. Fig. S3 A Control ZSTK474 6 5 Relative tumor size 4 3 2 1 PC-3 SK-OV3 0 B PC-3 SK-OV3 Control ZSTK474 Control ZSTK474 P-S6 100μm P-Rb Cleaved PARP

  4. Fig. S4 control ZSTK474 0h 12h 24h 72h DNA content (FL2A) Cell size (FSC-H)

More Related